| Market cap | $2.72B |
|---|---|
| Enterprise value | $2.88B |
| Revenue | $6.567B |
|---|---|
| EBITDA | $356.851M |
| Income | $193.860M |
| Revenue Q/Q | 0.95% |
| Revenue Y/Y | 2.78% |
| P/E | 12.44 |
|---|---|
| Forward P/E | 10.62 |
| EV/Sales | 0.44 |
| EV/EBITDA | 8.08 |
| EV/EBIT | 9.67 |
| PEG | 2.05 |
| Price/Sales | 0.41 |
| P/FCF | N/A |
| Price/Book | 2.43 |
| Book/Share | 10.44 |
| Cash/Share | 1.49 |
| FCF yield | -30.16% |
| Volume | 3.938M / 578.568k |
|---|---|
| Relative vol. | 6.81 × |
| EPS | 2.00 |
|---|---|
| EPS Q/Q | -25.58% |
| Est. EPS Q/Q | -1.72% |
| Profit margin | 3.21% |
|---|---|
| Oper. margin | 4.12% |
| Gross margin | 21.22% |
| EBIT margin | 4.54% |
| EBITDA margin | 5.43% |
| Ret. on assets | 6.69% |
|---|---|
| Ret. on equity | 18.23% |
| ROIC | 10.85% |
| ROCE | 18.00% |
| Debt/Equity | 1.58 |
|---|---|
| Net debt/EBITDA | 6.84 |
| Current ratio | 1.43 |
| Quick ratio | 0.72 |
| Volatility | 2.74% |
|---|---|
| Beta | 0.54 |
| RSI | 61.24 |
|---|
| Insider ownership | 10.87% |
|---|---|
| Inst. ownership | 83.66% |
| Shares outst. | 89.592M |
|---|---|
| Shares float | 0.000 0.00% |
| Short % of float | 6.77% |
| Short ratio | 5.33 |
| Dividend | $1.04 |
|---|---|
| Dividend yield | 4.55% |
| Payout ratio | 50.98% |
| Payment date | 2 Aug 2024 |
| Ex-dividend date | 19 Jul 2024 |
| Earnings date | 20 Jun 2024 |
Tuesday, 18 June 2024
|
|
| Patterson Companies Reports Fiscal 2024 Fourth Quarter and Year End Operating Results | |
Friday, 1 March 2024
|
|
| Patterson Dental and Vyne Dental Join Forces to Expedite Insurance Claim Processing for Eaglesoft Customers and Dental Practices | |
Thursday, 29 February 2024
|
|
| Patterson Companies, Inc. Q3 2024 Earnings Call Transcript | |
Friday, 29 December 2023
|
|
| Why Is Patterson Cos. Up 12.1% Since Last Earnings Report? | |
Monday, 27 November 2023
|
|
| What's in Store for Patterson Companies in Q2 Earnings? | |
Friday, 17 November 2023
|
|
| Are Investors Undervaluing Patterson Companies Right Now? | |
Sunday, 29 October 2023
|
|
| 14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds | |
Wednesday, 30 August 2023
|
|
| Q1 2024 Patterson Companies Inc Earnings Call | |
| Why Patterson Companies Stock Dropped Today | |
Monday, 31 July 2023
|
|
| A Look At The Fair Value Of Patterson Companies, Inc. | |
Friday, 7 July 2023
|
|
| 3 Top Healthcare Stocks to Buy for July | |
Thursday, 15 June 2023
|
|
| Patterson Companies Elects Meenu Agarwal to Board of Directors | |
Tuesday, 14 March 2023
|
|
| Patterson Companies Declares Regular Quarterly Cash Dividend | |
Monday, 23 January 2023
|
|
| Should You Investigate Patterson Companies, Inc. At US$28.90? | |
Monday, 9 January 2023
|
|
| Patterson Companies Has Affirmed Its Dividend Of $0.26 | |
Saturday, 17 December 2022
|
|
| Patterson Companies Will Pay A Dividend Of $0.26 | |
Thursday, 15 December 2022
|
|
| Patterson Companies Announces Enhancements to Executive Leadership Team | |
Wednesday, 14 December 2022
|
|
| 12 Biggest Dental Companies in the World | |
Monday, 12 December 2022
|
|
| Patterson Closes Acquisition of Dairy Tech | |
Monday, 5 December 2022
|
|
| Patterson Companies, Inc. Q2 2023 Earnings Call Transcript | |
Tuesday, 22 November 2022
|
|
| Patterson Companies Fiscal 2023 Second Quarter Conference Call Scheduled for Thursday, December 1, 2022 | |
Tuesday, 1 November 2022
|
|
| Return Trends At Patterson Companies Aren't Appealing | |
Friday, 14 October 2022
|
|
| Should You Hold Patterson Companies for the Long-Term? | |
Thursday, 13 October 2022
|
|
| Patterson Companies Announces Leadership Transition | |
| Insider |
Trans.
Transaction
|
Total value |
|---|---|---|
| Kevin Michael Barry Chief Financial Officer | Sale 15 Dec 2023 | $15,221 |
| Donald Zurbay President and CEO | Sale 5 Dec 2023 | $49,651 |
| Kevin Michael Barry Chief Financial Officer | Sale 1 Dec 2023 | $41,261 |
| Timothy E Rogan President - Dental | Sale 5 Oct 2023 | $275,485 |
| Donald Zurbay President and CEO | Sale 18 Jul 2023 | $182,538 |
| Les B Korsh CLO and Corporate Secretary | Sale 18 Jul 2023 | $119,684 |
| Les B Korsh CLO and Corporate Secretary | Sale 5 Jul 2023 | $29,365 |
| Donald Zurbay President and CEO | Sale 5 Jul 2023 | $53,878 |
| Les B Korsh CLO and Corporate Secretary | Sale 21 Jun 2023 | $111,125 |
| Kevin Michael Barry Chief Financial Officer | Sale 5 Dec 2022 | $274,791 |
| Donald Zurbay President and CEO | Sale 6 Jul 2022 | $301,124 |
Powered by
Robintrack.
Price target
Current $22.85
Average $26.25
Low $21
High $35
Dividends
| Ex-dividend date | 19 Jul 2024 | Frequency | Quarterly | Annual dividend | +0.00% |
|---|---|---|---|---|---|
| Next dividend | 2 Aug 2024 | Dividend yield | 4.55% | Growth period | 5 years |
| Last dividend date | Yield 3 years | 3.97% | Growth 3 years | +0.00% | |
| Last dividend | Yield 5 years | 3.79% | Growth 5 years | +0.00% |
| Insider | Age | Since | Compensation |
|---|---|---|---|
| Mark Walchirk (54) President, Chief Executive Officer, and Director since 2017 | 54 | 2017 | $5,859,500 |
| Mark S. Walchirk (55) CEO, Pres, and Director | 55 | $2,576,247 | |
| Donald Zurbay (52) Chief Financial Officer since 2018 | 52 | 2018 | $2,322,370 |
| Kevin Pohlman (57) President - Patterson Animal Health since 2017 | 57 | 2017 | $2,144,500 |
| Eric Shirley (54) President of Patterson Dental since 2019 | 54 | 2019 | $1,287,540 |
| Donald J. Zurbay (53) CFO and Treasurer | 53 | $1,276,594 | |
| Les Korsh (50) Vice President, General Counsel, and Secretary since 2015 | 50 | 2015 | $1,258,460 |
| Andrea Frohning (50) Chief Human Resource Officer since 2018 | 50 | 2018 | $1,175,240 |
| Eric R. Shirley (55) Sr. VP of Bus. Devel. - Patterson Dental | 55 | $850,521 | |
| Les B. Korsh (51) VP, Gen. Counsel, and Sec. | 51 | $838,146 | |
| Kevin M. Pohlman (58) Pres of Animal Health International and Inc. | 58 | $812,843 | |
| John Buck (70) Non-Executive Independent Chairman of the Board since 2017 | 70 | 2017 | $326,002 |
| Robert Frenzel (49) Independent Director since 2018 | 49 | 2018 | $281,002 |
| Alex Blanco (59) Independent Director since 2017 | 59 | 2017 | $277,252 |
| Francis Malecha (56) Independent Director since 2018 | 56 | 2018 | $272,252 |
| Jody Feragen (64) Independent Director since 2011 | 64 | 2011 | $242,877 |
| Neil Schrimsher (56) Independent Director since 2016 | 56 | 2016 | $234,752 |
| Ellen Rudnick (69) Independent Director since 2003 | 69 | 2003 | $231,002 |
| John Wright | 2015 | ||
| Andrea L. Frohning (51) Chief HR Officer | 51 | ||
| Paul A. Guggenheim (61) Chief Innovation Officer | 61 | ||
| Shivani Prabhakar Kaul | |||
| Dave M. Lardy |
patterson companies is an industry-leading specialty distributor serving the dental and veterinary supply markets. driven to meet the needs of healthcare professionals in these growing markets, patterson provides a total-package approach to doing business. dental market patterson dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout north america. veterinary market patterson veterinary supply and animal health international are leading distributors of consumable supplies, equipment and software, diagnostic products, vaccines and other pharmaceuticals to the companion pet, production animal, and farm/fleet store markets in the united states, canada and the united kingdom. visit our company website at www.pattersoncompanies.com/
- Health Care > Health Care Distributors
- Patterson Companies Inc., 1031 Mendota Heights Road, Saint Paul 55120, United States
- 651 686 1600
- Investor relations
Dividends
| Ex-dividend date | 19 Jul 2024 | Frequency | Quarterly | Annual dividend | +0.00% |
|---|---|---|---|---|---|
| Next dividend | 2 Aug 2024 | Dividend yield | 4.55% | Growth period | 5 years |
| Last dividend date | Yield 3 years | 3.97% | Growth 3 years | +0.00% | |
| Last dividend | Yield 5 years | 3.79% | Growth 5 years | +0.00% |
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
XSLX
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Current assets | |||||
| Cash | $114.462 | $123.998 | |||
| Short term investments | |||||
| Net receivables | $677.163 | $616.342 | |||
| Inventory | $782.898 | $902.733 | |||
| Total current assets | $1,778.763 | $1,832.563 | |||
| Long term investments | $166.32 | $164.459 | |||
| Property, plant & equipment | $351.376 | $334.519 | |||
| Goodwill & intangible assets | $349.589 | $359.593 | |||
| Total noncurrent assets | $1,117.969 | $1,107.386 | |||
| Total investments | $166.32 | $164.459 | |||
| Total assets | $2,896.732 | $2,939.949 | |||
| Current liabilities | |||||
| Accounts payable | $745.375 | $683.3 | |||
| Deferred revenue | |||||
| Short long term debt | $341.565 | $366.262 | |||
| Total current liabilities | $1,332.55 | $1,283.713 | |||
| Long term debt | $421.375 | $528.718 | |||
| Total noncurrent liabilities | $562.45 | $684.071 | |||
| Total debt | $762.94 | $894.98 | |||
| Total liabilities | $1,895 | $1,967.784 | |||
| Stockholders' equity | |||||
| Retained earnings | $831.483 | $802.884 | |||
| Other stockholder equity | -$89.915 | -$86.163 | |||
| Total stockholder equity | $1,001.144 | $971.482 | |||
| (in millions USD) | 2024 | 2023 | ||
|---|---|---|---|---|
| Current assets | ||||
| Cash | $114.462 | $159.669 | ||
| Short term investments | ||||
| Net receivables | $677.163 | $599.101 | ||
| Inventory | $782.898 | $795.072 | ||
| Total current assets | $1,778.763 | $1,783.136 | ||
| Long term investments | $166.32 | $160.022 | ||
| Property, plant & equipment | $351.376 | $305.239 | ||
| Goodwill & intangible assets | $349.589 | $388.293 | ||
| Total noncurrent assets | $1,117.969 | $1,096.01 | ||
| Total investments | $166.32 | $160.022 | ||
| Total assets | $2,896.732 | $2,879.146 | ||
| Current liabilities | ||||
| Accounts payable | $745.375 | $724.993 | ||
| Deferred revenue | ||||
| Short long term debt | $341.565 | $109.39 | ||
| Total current liabilities | $1,332.55 | $1,085.332 | ||
| Long term debt | $421.375 | $518.607 | ||
| Total noncurrent liabilities | $562.45 | $675.279 | ||
| Total debt | $762.94 | $627.997 | ||
| Total liabilities | $1,895 | $1,760.611 | ||
| Stockholders' equity | ||||
| Retained earnings | $831.483 | $972.127 | ||
| Other stockholder equity | -$89.915 | -$89.262 | ||
| Total stockholder equity | $1,001.144 | $1,117.535 | ||
Income statement
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | $1,722.66 | $1,616.095 | |||
| Cost of revenue | $1,351.505 | $1,265.089 | |||
| Gross profit | $371.155 | $351.006 | |||
| Operating activities | |||||
| Research & development | |||||
| Selling, general & administrative | $283.368 | $280.994 | |||
| Total operating expenses | $283.368 | $280.994 | |||
| Operating income | $87.787 | $70.012 | |||
| Income from continuing operations | |||||
| EBIT | $100.271 | $73.775 | |||
| Income tax expense | $20.204 | $14.347 | |||
| Interest expense | $13.031 | $11.725 | |||
| Net income | |||||
| Net income | $67.036 | $47.703 | |||
| Income (for common shares) | $67.036 | $47.703 | |||
| (in millions USD) | 2024 | 2023 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6,568.272 | $6,471.471 | ||
| Cost of revenue | $5,188.03 | $5,098.526 | ||
| Gross profit | $1,380.242 | $1,372.945 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1,127.318 | $1,096.974 | ||
| Total operating expenses | $1,127.318 | $1,096.974 | ||
| Operating income | $252.924 | $275.971 | ||
| Income from continuing operations | ||||
| EBIT | $288.375 | $304.756 | ||
| Income tax expense | $57.534 | $63.563 | ||
| Interest expense | $44.91 | $33.636 | ||
| Net income | ||||
| Net income | $185.931 | $207.557 | ||
| Income (for common shares) | $185.931 | $207.557 | ||
Cash flows
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Net income | $67.036 | $47.703 | |||
| Operating activities | |||||
| Depreciation | $22.958 | $22.362 | |||
| Business acquisitions & disposals | $257.958 | $280.867 | |||
| Stock-based compensation | $2.476 | $3.745 | |||
| Total cash flows from operations | -$69.529 | -$234.573 | |||
| Investing activities | |||||
| Capital expenditures | -$16.43 | -$17.729 | |||
| Investments | |||||
| Total cash flows from investing | $241.528 | $263.138 | |||
| Financing activities | |||||
| Dividends paid | -$23.312 | -$24.69 | |||
| Sale and purchase of stock | -$14.921 | -$124.096 | |||
| Net borrowings | -$145.75 | $127.25 | |||
| Total cash flows from financing | -$181.814 | -$20.91 | |||
| Effect of exchange rate | $0.279 | $2.457 | |||
| Change in cash and equivalents | -$9.536 | $10.112 | |||
| (in millions USD) | 2024 | 2023 | ||
|---|---|---|---|---|
| Net income | $185.931 | $207.557 | ||
| Operating activities | ||||
| Depreciation | $88.156 | $83.704 | ||
| Business acquisitions & disposals | $1,027.169 | $965.632 | ||
| Stock-based compensation | $17.871 | $15.543 | ||
| Total cash flows from operations | -$789.378 | -$754.852 | ||
| Investing activities | ||||
| Capital expenditures | -$67.626 | -$64.22 | ||
| Investments | -$15 | |||
| Total cash flows from investing | $959.543 | $901.567 | ||
| Financing activities | ||||
| Dividends paid | -$98.333 | -$101.346 | ||
| Sale and purchase of stock | -$229.508 | -$55.492 | ||
| Net borrowings | $105 | $14.5 | ||
| Total cash flows from financing | -$215.905 | -$126.484 | ||
| Effect of exchange rate | $0.533 | -$2.576 | ||
| Change in cash and equivalents | -$45.207 | $17.655 | ||
Recent institutional transactions
| Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|---|
| 2024 Q1 | Ubs Asset Management Americas |
+328.97%
|
418,880 | $11,582,032 |
| 2024 Q1 | Russell Investments |
+1,802.50%
|
67,615 | $1,869,560 |
| 2024 Q1 | Neuberger Berman Group |
+5.00%
|
1,337,301 | $36,980,976 |
| 2024 Q1 | Martingale Asset Management L P |
-51.83%
|
33,242 | $919,142 |
| 2024 Q1 | Dean Investment Associates |
-15.80%
|
104,904 | $2,900,596 |
| 2024 Q1 | Foster & Motley Inc |
+10.18%
|
102,325 | $2,826 |
| 2024 Q1 | Legato Capital Management |
-14.84%
|
35,917 | $993,105 |
| 2024 Q1 | Yousif Capital Management |
-11.25%
|
37,684 | $1,041,963 |
| 2024 Q1 | Whittier Trust Co |
-50.00%
|
25 | $691 |
| 2024 Q1 | Whittier Trust Co Of Nevada Inc |
Opened
|
25 | $691 |
Institutional shareholders
| Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|
| Neuberger Berman Group | 1.49% | 1,337,301 | |
| Ubs Asset Management Americas | 0.47% | 418,880 | |
| Kayne Anderson Rudnick Investment Management | 0.30% | 271,912 | |
| Peregrine Capital Management | 0.25% | 227,468 | |
| Tavio Capital | 0.23% | 202,943 | |
| Tiaa Cref Investment Management | 0.18% | 157,775 | |
| Dean Investment Associates | 0.12% | 104,904 | |
| Foster & Motley Inc | 0.11% | 102,325 | |
| Great Lakes Advisors | 0.10% | 89,958 | |
| Ing Investment Management Co | 0.09% | 76,825 |
Sign up